"Huge step for the future of cannabis"

US: Company receives federal license to manufacture and sell cannabis

Maridose LLC has received a Federal license from the United States Department of Justice and Drug Enforcement Agency for the bulk manufacture of cannabis to supply researchers with any or all of the following Schedule 1 products: cannabis, cannabis extract (including isolated chemical constituents), and tetrahydrocannabinols (THC).

For decades the University of Mississippi had a monopoly on cannabis grown for research. The license granted to Maridose is a step toward ending that monopoly and expanding access to modern cannabis strains for research on cannabis and cannabis-derived products.

Maridose is now an alternative to the University of Mississippi and is licensed by the Drug Enforcement Agency to supply cannabis and its extracts for research use in the United States. "We are very excited to receive this license from the DEA to produce and sell cannabis for research purposes. This a huge step for science and the future of cannabis.", said Richard Shain, Maridose's Founder, "Our DEA Registration Number RM063095 is the culmination of over five years of working with the DEA and enables Maridose to legally sell a wide variety of cannabis products through the DEA to researchers and DEA-licensed pharmaceutical companies in the United States and internationally. The DEA has indicated that it will only issue a very limited number of them, and Maridose is proud to be one of the first companies to receive a license. Cannabis businesses operating in states that have state-legal cannabis are unable to ship across state lines and operate at legal risk because cannabis remains a Schedule 1 substance at the federal level. Maridose is able to legally supply our customers without these risks and limitations."

For more information:
Maridose 
www.maridose.com

 


Publication date:



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber